Crossref
The PEGylation paradox: Limitations, failures, and emerging alternatives in lipid nanoparticle delivery
Journal of Advanced Pharmaceutical Sciences · 25.06.2026 · 3 (2) · 56-66
DOI: 10.21608/japs.2026.495194.1069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Pharmaceutical Sciences, online erschienen am 25.06.2026. Verfasst von Alaa Aboushanab und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aboushanab, A., & El-Kamel, A. H. (2026). The PEGylation paradox: Limitations, failures, and emerging alternatives in lipid nanoparticle delivery. Journal of Advanced Pharmaceutical Sciences, 3(2), 56-66. https://doi.org/10.21608/japs.2026.495194.1069
Vancouver
Aboushanab A, El-Kamel AH. The PEGylation paradox: Limitations, failures, and emerging alternatives in lipid nanoparticle delivery. Journal of Advanced Pharmaceutical Sciences. 2026;3(2):56-66. doi:10.21608/japs.2026.495194.1069
BibTeX
@article{Aboushanab2026,
author = {Aboushanab, Alaa and El-Kamel, Amal Hassan},
title = {The PEGylation paradox: Limitations, failures, and emerging alternatives in lipid nanoparticle delivery},
journal = {Journal of Advanced Pharmaceutical Sciences},
year = {2026},
volume = {3},
number = {2},
pages = {56--66},
doi = {10.21608/japs.2026.495194.1069}
}
EUVIMED